Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac Buccal Infiltration for IANB Success in Irreversible Pulpitis
NCT02536430Phase 2Completed
- Start
- Mar 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac in irreversible pulpitis. Started Mar 2015; status: completed.
02
Drugs
ketorolac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT02536430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536430.